Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)
34.80
-0.20 (-0.57%)
Nov 3, 2025, 2:45 PM CST
SHE:002422 Revenue
Sichuan Kelun Pharmaceutical had revenue of 4.19B CNY in the quarter ending September 30, 2025, a decrease of -15.48%. This brings the company's revenue in the last twelve months to 18.30B, down -18.66% year-over-year. In the year 2024, Sichuan Kelun Pharmaceutical had annual revenue of 21.81B with 1.67% growth.
Revenue (ttm)
18.30B
Revenue Growth
-18.66%
P/S Ratio
3.03
Revenue / Employee
837.01K
Employees
21,864
Market Cap
55.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21.81B | 358.49M | 1.67% |
| Dec 31, 2023 | 21.45B | 2.42B | 12.69% |
| Jan 1, 2023 | 19.04B | 1.76B | 10.19% |
| Jan 1, 2022 | 17.28B | 813.21M | 4.94% |
| Dec 31, 2020 | 16.46B | -1.17B | -6.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 43.09B |
| WuXi AppTec | 43.07B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Medicine | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |